Medical AI Startup PaiYiPai Launches Equity Financing on 360 Taojin

VCBeat (WeChat ID: vabeat) recently learned that PaiYiPai, a technology service company specializing in visual recognition for medical imaging, has listed on 360 Taojin to initiate equity financing. As the first “Internet + Healthcare” project on the 360 Taojin platform, PaiYiPai has garnered keen interest and discussion from investors since its preliminary promotion, driven by its focus on “artificial intelligence” and “big data recognition.”

As medical demands continue to grow, the integration and application of artificial intelligence in the healthcare industry have become increasingly close. 2016 marked the inaugural year for medical innovation and entrepreneurship, with top-tier investment firms listing "Internet Healthcare" among their top five areas of focus. Globally, a comprehensive exploration model for intelligent healthcare has been initiated, and the major trends in new medical policies and strategic directions have been firmly established. These developments signify the true arrival of the era of intelligent medicine.

MEDP.AI has leveraged over 40 key national patents and related intellectual property rights, including photo recognition of medical documents and medical data parsing capabilities, to realize the application of artificial intelligence in the healthcare sector. Currently, it manages hundreds of millions of medical documents, with a document volume leading among similar companies in China.

The founding team of MEDP.AI consists of several top-tier scientists. CEO Wu Shizhan is a renowned big data expert in China, having previously led Baidu’s commercial database team and served as Chief DBA at Ganji.com. Co-founder Yang Qiong was formerly with Microsoft Research Asia and founded Baidu’s OCR team.

Currently, MEDP.AI’s commercial partnerships are focused on large-scale B-end medical institutions, delivering deep integration of core services with entities such as West China Hospital, Ciming Health Checkup, Bethune Blood Purification Center, Taikang Life Insurance, and Huadao Data (the largest third-party claims data entry company in China).

To achieve broader medical informatization services, Pai Yi Pai established an independent subsidiary, Xinze Medical, this year to manage and operate both in-hospital and out-of-hospital medical data, thereby precisely accelerating the company's overall development.

Leveraging its exceptional technological innovation capabilities and big data operational expertise, MEDP.AI emerged in 2016 as a benchmark enterprise in medical technology innovation, ranking first in multiple niche segments of healthcare technology services.

At the capital level, PaiYiPai’s Series A investors include New Vision Ventures (which has a medical background), Union Capital, Hongtai Fund, and Han Xiaohong of Ciming Health Checkup. Its angel investor was the globally renowned investment firm Redpoint Ventures. By joining 360 Taojin, PaiYiPai is optimistic about its superior financing model and the resources connected behind it.

360 Taojin is a top-tier private equity platform. Its innovative forward-pricing model has helped 70% of its projects secure subsequent institutional investment. With rigorous project screening, 360 Taojin’s listing of MEDP.AI further demonstrates its endorsement of the MEDP.AI project.

360 has conducted unique explorations and research in the field of artificial intelligence, with its Chief Scientist, Professor Yan Shuicheng, being a leading expert in AI. The integration of resources between MEDP.AI and 360 is likely to achieve win-win outcomes in both technology and capital sectors.